All the news Showing 10 of 31 articles from: Deciding when and how to treat HCVGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources US docs hold back patients until new HCV drugs arrive Pharma Times / 06 November 2013 Studies: Current hepatitis C treatments can't be used by more than half of patients; others lose opportunity for treatment Henry Ford Health System press release / 01 November 2013 Treat Now or Later in HCV? Expert Guidance for Individual Scenarios Clinical Care Options / 28 October 2013 Enter the Nonspecialist: Will Evolving Hepatitis C Therapies Reduce the Need for Specialized Care? Clinical Care Options (requires registration) / 14 October 2013 A Significant Share of Surveyed Treatment-Naive and Prior Failure HCV Patients Plan to Initiate an HCV Treatment Regimen in the Next Year PR Newswire (press release) / 10 September 2013 People with HIV/HCV co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease Michael Carter / 10 September 2013 People living with HIV who have hepatitis C virus (HCV) co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease even though they do not have cirrhosis of the liver, ... Fear of future health problems encourage people to start and complete HCV therapy but concern about side-effects is a deterrent Michael Carter / 27 June 2013 US research has provided important insights into the factors that motivate and deter people from starting and completing therapy for hepatitis C virus (HCV) infection. Published in the online journal BMC Infectious Diseases, the ... Troubling Concerns About Hepatitis C Treatment Lucinda Porter (blog) / 12 June 2013 Drugs Go From Hit to Dud in Two Years in Hepatitis Race Bloomberg / 04 June 2013 The Majority of Physicians Have Begun “Warehousing” and Preparing Their HCV Patients for the Next Generation of HCV Treatments BioTrends Research Group press release / 24 May 2013 ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive